Author

R.-U. Rahman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:differential expression· 2 Research Focus:host-pathogen & immune response· 2 Assay:metagenomics· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

H. Amatullah· 2 shared A. C. Mullen· 1 shared C. Sun· 1 shared D. Wrobel· 1 shared F. Adiliaghdam· 1 shared I. Fraschilla· 1 shared J. F. Doerner· 1 shared J. F. Rippmann· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

H. Amatullah

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivMar 29, 2022

Immune chromatin reader SP140 regulates microbiota and risk for inflammatory bowel disease

I. Fraschilla, H. Amatullah, R.-U. Rahman, K. Jeffrey

This study identifies SP140's role in regulating microbiota and preventing inflammatory bowel disease by controlling inflammatory bacteria.

DOI 10.1016/j.chom.2022.08.018

𝕏 PostBluesky

ImmunologybioRxivPreprintOct 14, 2021

Human enteric viruses shape disease phenotype through divergent innate immunomodulation

F. Adiliaghdam, H. Amatullah, S. Digumarthi…·K. L. Jeffrey

The paper shows that human viromes from healthy and IBD patients differentially modulate innate immunity, influencing disease phenotypes through nucleic acid sensing.

DOI 10.1101/2021.10.14.464404

humanmetagenomics

𝕏 PostBluesky

Cell BiologybioRxivOct 8, 2021

Nanchangmycin regulates FYN, FAK and ERK to control the fibrotic activity of hepatic stellate cells

W. Li, J. Y. Chen, C. Sun…·A. C. Mullen

This study identifies nanchangmycin as an anti-fibrotic agent that inhibits HSC myofibroblast activity by modulating FYN, FAK, and ERK signaling pathways.

DOI 10.7554/elife.74513

humanexperimental assay

𝕏 PostBluesky